Calls Now Open
2022 ADDF-Harrington and 2023 Harrington UK Rare Disease Programs
Jan Rosenbaum, PhD is President, CEO and CSO of Kurome. She is a drug development professional, chief scientific officer, and innovator with more than 25 years of pharma/biotech technical management experience.
Dr. Rosenbaum is the former chief scientific officer of Airway Therapeutics, a 2011 spin-out of CCHMC that is also a CincyTech portfolio company. In addition, she serves as a business development advisor on the Therapeutics Development Team of the Harrington Discovery Institute, University Hospitals, Cleveland, OH, and chairs the Science & Industry Advisory Committee for IRICoR, University of Montréal, Canada.
She holds a Visiting Scholar position in the Department of Pharmacology and Systems Physiology, where she co-created and teaches a Drug Discovery course for graduate students each Fall semester at the UC Medical Center.